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ABSTRACT 
Objective. We seek to derive a predictive model to identify patients likely to be 
hospitalized during the following year due to complications attributed to Type II diabetes.  
Methods. We test a variety of supervised machine learning classification methods and 
develop a new method that discovers hidden patient clusters in the positive class 
(hospitalized) while, at the same time, derives sparse linear support vector machine 
classifiers to separate positive samples from the negative ones (non-hospitalized). We 
establish the convergence of the new method and prove guarantees on how the classifiers 
it produces generalize to a test set not seen during training.     
Results. We test the methods on a large set of patients from the Boston Medical Center – 
the largest safety net hospital in New England. Our new joint clustering/classification 
method achieves an accuracy of 89% (measured in terms of Area Under the ROC Curve) 
and yields informative clusters which can help interpret the classification results, thus, 
increasing the trust of physicians to the algorithmic output and providing some guidance 
towards preventive measures. While it is possible to increase accuracy to 92% with other 
methods, this comes with increased computational cost and lack of interpretability. Our 
analysis shows that even a modest probability of preventive actions being effective (more 
than 19%) suffices to generate significant hospital care savings. 
Conclusions. We propose predictive models that can help avert hospitalizations, improve 
health outcomes and drastically reduce hospital expenditures. The scope for savings is 
significant as it has been estimated that in the U.S. alone about $5.8 billion are spent each 
year on diabetes-related hospitalizations that could be prevented.  
Keywords:  
diabetes mellitus, hospitalization prediction, Electronic Health Records, clustering, 
classification. 
 
  
1. BACKGROUND AND SIGNIFICANCE 
Diabetes is recognized as the world’s fastest growing chronic condition. One in eleven 
adults has diabetes worldwide (415 million) and 12% of global health expenditures is spent 
on diabetes ($673 billion).[1] In the U.S. alone, 29.1 million people or 9.3% of the 
population had diabetes in 2012.[2] Given its impact, medical and health services studies 
have been tracking the prevalence and trends in diabetes among adults.[3–5] While 
diabetes affects primarily the patients at many levels (physical, financial, etc.), it also poses 
an economic burden to states influencing healthcare costs and GDP/productivity metrics.   
 
The U.S. healthcare system is undoubtedly expensive, excellent at treating acute conditions 
but ineffective at keeping patients out of the hospital.[6, 7] Hospital care accounts for 31% 
of U.S. healthcare spending,[8] the latter totaling $3 trillion or 17% of GDP annually. A 
recent study, however, found that nearly $30.8 billion in hospital costs in year 2006 were 
potentially avoidable,[9] with diabetes-related hospitalizations accounting for 19% ($5.8 
billion) of this amount. Consequently, even a modest percentage reduction in unnecessary 
hospitalizations, achieved by better controlling the disease in an outpatient setting, can 
result in sizeable savings. Prevention requires prediction and this motivates the work in 
this paper.  
 
Two key enablers to such research are: the growing availability of patient Electronic Health 
Records (EHR) and the existence of sophisticated algorithms that can learn from the data. 
Surprisingly, not until recently have EHRs been used in conjunction with advanced 
algorithms,[10, 11] even though they have been shown to lead to better care. [12] Predictive 
methods, in particular, have been used for example in the context of heart-related 
problems,[13–15] hemodialysis,[16] diabetes in older adults,[17–20] and multiple disease 
prediction.[21] To the best of our knowledge, predicting diabetes-related hospitalizations 
based on EHR history using machine learning algorithms is a novel problem.  
 
Diabetes mellitus is a set of metabolic diseases affecting the body’s ability to modulate 
blood sugar levels. Type I affects younger patients and is caused by the inability of the 
pancreas to produce enough insulin. Type II appears in older people when cells develop 
insensitivity to insulin. Gestational diabetes appears during pregnancy. Type II diabetes is 
by far the most common and in this paper we focus on patients with this type. Diabetes 
complications include nephropathy, neuropathy, retinopathy, vasculopathy (leading to 
heart disease and stroke), and foot ulcers. Many of these complications can lead to 
hospitalization, however, it is estimated that about 40% such hospitalizations do not list 
diabetes as a primary/secondary diagnosis.[22] To remove potential biases in the EHR, we 
will use a statistical method to associate different hospitalization types with diabetes. 
2. OBJECTIVE 
We seek to predict hospitalizations associated with Type II diabetes within one year from 
the time the EHR of a patient is examined. We will treat hospitalization prediction as a 
classification problem, distinguishing between patients likely to be hospitalized or not. 
Intuitively, however, patients belong to different clusters depending on their demographics 
and ailments that are likely to cause a future hospitalization. Common supervised learning 
methods can certainly make classifications without considering these hidden clusters; yet, 
identifying the clusters can potentially improve classification performance. More 
importantly, hidden cluster identification yields results that are easier to interpret.   
 
Patients in the same cluster, especially if the cluster is identified based on a low-
dimensional subspace of “diagnostic” features, share key characteristics (including 
potentially race and ethnicity) and their cluster membership offers an explanation as to why 
they have been flagged for a future hospitalization. In the medical setting, interpretability 
has an essential role in persuading physicians to trust the learning outputs and rely on them 
for their decision making. EHRs exhibit interesting special structure in that for each patient 
only a very low-dimensional subset of features is important in predicting a future 
hospitalization. This subset is different for each cluster and, typically, there is no universal 
set of irrelevant features that can be eliminated.[13, 23] This suggests that it is useful to 
consider sparse classifiers for each cluster. Sparse models have gained popularity in the 
literature for their interpretability and superior (out-of-sample) performance.[24, 25] 
 
The remainder of the paper is organized as follows. In Section 3, we discuss methods we 
apply to the hospitalization prediction problem. We propose a novel method, an alternating 
optimization approach, which jointly discovers the clusters in the class of hospitalized 
patients and optimizes the classifiers that separate each cluster of hospitalized patients from 
the non-hospitalized patients. We establish the convergence of this joint 
clustering/classification process and characterize its Vapnik-Chervonenkis (VC) 
dimension [26]  ̶  a metric of complexity of the classification function that can lead to 
generalization guarantees. In Section 4, we describe the dataset used in our experiments 
and in Section 5 we present our experimental results. Conclusions are in Section 6.  
 
3. METHODS 
We formulate the hospitalization prediction problem as a binary supervised classification 
problem. For each patient we derive features from the EHR and we seek to differentiate 
between patients that will be hospitalized in a fixed target year (positive class) and patients 
that will not be admitted to the hospital in the target year (negative class). During the 
training of each classification model, both the features and the labels of the training set 
patients are known to the algorithm. We explore a variety of learning methods, such as 
Support Vector Machines (SVMs) with various kernels [27], random forests [28, 29], and 
the more computationally expensive gradient tree boosting.[29, 30] We also experiment 
with sparse (𝑙ଵ-regularized) versions of some algorithms; specifically, sparse SVMs and sparse logistic regression.  
3.1 Our Alternating Clustering and Classification (ACC) 
framework 
To develop this new framework, we consider a classification problem that has multiple 
hidden clusters in the positive class, while the negative class is assumed to be drawn from 
a single distribution. For different clusters in the positive class, we assume that the 
discriminative dimensions, with respect to the negative class, are different and sparse. We 
could think of these clusters as “local opponents” to the whole negative set (see Figure 1) 
and therefore, the “local boundary” (classifier) could naturally be assumed to be different 
and lying in a lower-dimensional subspace of the feature vector.  
 
 
Figure 1: An example with two clusters in the positive class (red circles) separated by 
two different classifiers from the negative class (blue squares). 
 
We propose a joint cluster detection and classification problem under the SVM framework. 
Let ሺ𝒙𝒊ା, 𝑦௜ାሻ, 𝑖 ൌ 1, … , 𝑁ା , denote the (𝐷 ൅ 1ሻ െdimensional positive samples, where 𝒙𝒊ା is the 𝐷 െdimensional feature vector of sample 𝑖 and 𝑦௜ା ൌ 1 the class label. Similarly, ሺ𝒙𝒋 , 𝑦௝ି ሻ, 𝑗 ൌ 1, … , 𝑁ି, denote the negative samples with 𝑦௜ି ൌ െ1. Assuming 𝐿 hidden 
clusters in the positive class, we wish to discover the L clusters (denoted by a mapping 
function 𝑙ሺ𝑖ሻ: ሼ1, … , 𝑁ାሽ → ሼ1, … , 𝐿ሽ) and 𝐿 sparse linear SVM classifiers, one for each 
cluster. Let ൫𝜷𝒍, 𝛽଴௟ ൯ be the vector orthogonal to the SVM hyperplane for cluster 𝑙. Let also 
𝑇௟ be a parameter controlling local per-cluster sparsity. The joint problem is: 
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𝜉௜௟ሺ௜ሻ, 𝜁௝௟ ൒ 0, ∀𝑖 ൌ 1, … , 𝑁ା,           𝑗 ൌ 1, … , 𝑁ି. 
 
The negative samples are not clustered but simply copied into each cluster. So their 
empirical costs are counted 𝐿 times as shown in (1). The relative weight of costs from 
negative samples compared to that of the positive samples is controlled by 𝜆ିand 𝜆ା. The 
constraint ∑ ห𝛽ௗ௟ ห ൑ 𝑇௟஽ௗୀଵ  is an 𝑙ଵ െrelaxation of the sparsity requirement for the local 
classifiers.  
 
Problem (1) involves two sets of decision variables: ൫𝜷௟, 𝛽଴௟ ൯ for the classifiers and 𝑙ሺ𝑖ሻ for 
cluster assignment. As we have shown in [15], the problem is a mixed integer programming 
problem, but given 𝑙ሺ𝑖ሻ it reduces to 𝐿 quadratic optimization problems. This motivates the 
alternating optimization approach we present next. Preliminary work on such a method was 
reported in [15] for the problem of predicting hospitalizations due to heart diseases. The 
approach contains two major modules: (i) training a classifier for each cluster and (ii) re-
clustering samples given all the estimated classifiers using a subset of “diagnostic” features 
∁. Note that since only positive samples belong to different clusters, only these samples 
need to be re-clustered. During the training phase, we alternate between (i) –training L 
sparse classifiers- and (ii) –re-clustering the positive samples given the classifiers- until 
convergence. The algorithm for training and testing in the ACC framework is shown in 
Table I. Algorithm 1 describes the training process, while Algorithm 2 provides details on 
how we re-cluster the positive samples given the classifiers learnt in (i). We note that 
training a sparse linear SVM classifier amounts to solving a quadratic programming 
problem, which can be done efficiently (in polynomial time to the size of the input, which 
is linear in the number of sample points in a cluster and the number of features D).    
 
Once training has been performed with Algorithm 1, we can classify a newly presented 
sample not seen during training using Algorithm 3. Specifically, we compute the 
projections on each classifier and assign the new sample to the cluster with the largest 
projection value. We use the classifier of this cluster to classify the samples in the 
corresponding cluster. We note that tuning 𝜆ା and 𝜆ି  in ACC should be done globally, 
i.e., 𝜆ା and 𝜆ି should be fixed across all clusters to guarantee convergence. 
 
Algorithm 1 Alternating Clustering and Classification Training 
Initialization: 
For 𝑖 ൌ 1, … , 𝑁ା, assign positive class sample 𝑖 to cluster 𝑙ሺ𝑖ሻ ∈ ሼ1, … , 𝐿ሽ (e.g., 
randomly). 
repeat 
Classification Step: 
Train a sparse linear SVM classifier for each cluster. Each classifier is the outcome of a 
quadratic optimization (similar to (1) but specific to a single cluster) providing ൫𝜷௟, 𝛽଴௟ ൯ 
and an optimal objective value 𝑂௟. 
Re‐clustering Step: 
Re‐cluster the positive samples using Alg. 2 and update the assignments 𝑙ሺ𝑖ሻ. 
until no 𝑙ሺ𝑖ሻ is changed or ∑ 𝑂௟௟  does not decrease. 
Algorithm 2 Re‐clustering procedure given classifiers 
Input: positive samples 𝒙௜ା, classifiers ൫𝜷௟, 𝛽଴௟ ൯, current clusters assigning 𝑖 to cluster 
𝑙ሺ𝑖ሻ. 
For 𝑖 ∈ ሼ1, … , 𝑁ାሽ do 
for all 𝑙 ∈ ሼ1, … , 𝐿ሽ do 
calculate the projection 𝑎௜௟ ൌ 𝒙௜,∁ᇱ 𝜷∁௟  of positive sample 𝑖 onto the classifier for cluster 
𝑙 in the feature subspace corresponding to ∁ ⊆ ሼ1, … , 𝐷ሽ . 
end for 
update the cluster assignment of sample 𝑖 from 𝑙ሺ𝑖ሻ to 𝑙∗ሺ𝑖ሻ ൌ arg 𝑚𝑎𝑥௟𝑎௜௟, subject to 
𝒙௜ାᇲ𝜷௟∗ሺ௜ሻ ൅ 𝛽଴௟
∗ሺ௜ሻ ൒ 𝒙௜ାᇲ𝜷௟ሺ௜ሻ ൅ 𝛽଴௟ሺ௜ሻ.                                                           (2) 
end for 
Algorithm 3 Classifying a new sample. 
Input: A new (test) sample 𝒙. 
Assign 𝒙 to cluster 𝑙∗ ൌ arg 𝑚𝑎𝑥௟ 𝒙∁ᇱ 𝜷∁௟ . 
Classify 𝒙 with the classifier ൫𝜷௟∗, 𝛽଴௟∗൯ by sgnሺ𝒙′𝜷௟∗ ൅ 𝛽଴௟∗ሻ. 
Table I: ACC training & testing. 
Theorem I establishes the convergence of ACC, while Theorem II characterizes its Vapnik-
Chervonenkis (VC) dimension [26] and provides theoretical generalization guarantees. 
Intuitively, if we adopt a more complex model to fit a set of training samples, the model is 
more likely to be overfitting and has a lower chance to generalize well to the test samples. 
The VC-dimension offers a theoretical way of quantifying the complexity of a model and 
leads to a relationship between the training and the test error rate. Linear classifiers in the 
D dimensional space have VC-dimension D ൅ 1. [26] The proofs of the two theorems are 
presented in Appendices A and B, respectively.  
 
Let 𝐻 denote the family of clustering/classification functions produced by ACC, where 𝐷 
denotes the maximum number of features used by a classifier. Let 𝑅ேሺℎሻ (or simply 𝑅ே) denote the training error rate of classifier ℎ on 𝑁 training samples randomly drawn from 
an underlying distribution 𝑃. Let 𝑅ሺℎሻ (or simply 𝑅) denote the expected test error of ℎ 
with respect to 𝑃.  
 
Theorem I For any ∁, the ACC process converges. 
 
Theorem II The VC-dimension of the class H is bounded by 𝑉஺஼஼ ൌ ሺ𝐿 ൅ 1ሻ𝐿ሺ𝐷 ൅
1ሻlog ሺ௘ሺ௅ାଵሻ௅ଶ ሻ. Then for any 𝜌 ∈ ሺ0,1ሻ, with probability at least 1 െ 𝜌, 𝑅 ൑ 𝑅ே ൅
2ඨ2 ௏ಲ಴಴௟௢௚
మ೐ಿ
ೇಲ಴಴ା௟௢௚
మ
ഐ
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Theorem I guarantees that for any choice of the subset ∁ of ‘informative features’ used for 
the re-clustering of the positive samples in Algorithm 2, the ACC process converges. We 
note that the joint problem (1) is non-convex, which suggests that a globally optimal 
solution is hard to obtain. ACC is a local optimization method and it is only guaranteed to 
converge to a local optimal solution. Strategies such as multi-start (i.e., starting from 
several initial points, using ACC until convergence, and retaining the best local minimum 
found) can be adopted to find a “deep” local optimum. The joint problem (1) can also be 
formulated as a maximization of a log-likelihood function (using the hinge-loss 
formulation of the SVM classifiers and raising it to an exponent), where cluster 
membership can be captured by latent indicator variables. In such a formulation, ACC can 
be seen as a particular implementation of the EM algorithm [31], where the E-step 
corresponds to cluster assignment and the M-step to obtaining classifiers for each cluster.  
It is possible to accelerate the speed of convergence by reducing the amount of work in the 
E-step, which is linear in the number of training samples. One possible approach has been 
used in [32]; specifically, rather than assigning all training samples to a cluster in each 
iteration, select a subset of samples, assign them to cluster, and then perform the per cluster 
classification steps. In our setting, 𝑁 ൌ 𝑁ା ൅ 𝑁ି  is large (on the order of tens of 
thousands) but not extremely large and we did not find necessary to test such an approach.    
 
Theorem II states that the out-of-sample error is close to the training error with high 
probability, which provides a rigorous generalization guarantee of our method. 
 
3.2 Performance evaluation 
To measure accuracy, the dataset is split into a training and a test set. The classification 
models are then trained using the features and the labels of the patients in the training set. 
In the testing phase, the models, given the patient’s features, predict the corresponding 
label, which can be directly compared to the ground truth label. We report two error 
metrics: the detection rate (also referred to as sensitivity), which measures how many 
patients out of the truly hospitalized patients were predicted to be hospitalized, and the 
false alarm rate (equals one minus the so called specificity), which measures how many 
patients out of the truly non-hospitalized were predicted to be hospitalized.1 Two other 
related metrics are the precision, defined as the ratio of the number of the truly hospitalized 
over the number of the predicted to be hospitalized,  and the recall, which is the same as 
the detection rate or sensitivity. Many pairs of these error metrics can be generated by 
changing the decision threshold in the classification models. We plot the detection rate 
versus the false alarm rate in the Receiver Operating Characteristic (ROC) curve and the 
precision versus the recall in the Precision-Recall Curve (PRC). Typically, one chooses a 
point on the ROC (or PRC) to operate on, depending on the application, i.e., how high false 
alarm rate or low detection rate one can afford. The Area Under the ROC Curve (AUC) 
and the Area Under the Precision-Recall Curve (AUC-PR) are summary statistics, taking 
values between 0 and 1, that allow us to compare different ROC and PRC curves, 
respectively. The higher the AUC (AUC-PR) value of the ROC (PRC) curve, the better. A 
completely random assignment of patients into the two classes (hospitalized and non-
hospitalized) has an AUC of 0.5 and an AUC-PR equal to the proportion of positive 
samples (precision is constant despite of the changing recall in the PRC). It is worth noting 
that unlike the ROC curve, the PRC is not guaranteed to be monotonic. [33] 
 
While ROC curves could provide misleading interpretation of specificity when utilized in 
imbalanced classification cases,[34, 35] (i.e., when one class has many more samples than 
the other), the PRC presents a more accurate measurement of imbalanced classification 
performance because it also considers the fraction of true positive samples among all 
positive predictions.[34, 35] In the diabetes-related hospitalization prediction problem 
under consideration, this imbalance is present as there are many more non-hospitalized 
patients than hospitalized. Consequently, we present both ROC (AUC) and PRC (AUC-
PR) curves to enable a comprehensive understanding of the classification performance. 
 
As we commented earlier, the interpretability of the results is critical in ensuring practical 
use. We will assess interpretability in terms of highlighted important features that are the 
most helpful into making the classification decision. In the ACC approach, the discovered 
clusters bear a lot of information as to why the hospitalization occurred. To visualize this 
information, we listed the most distinguishable mean feature values over the patients in 
each cluster, which correspond to key features shared by the patients in the cluster. 
4. MATERIALS: THE DIABETES DATASET 
The data used for the experiments come from Boston Medical Center (BMC). BMC is the 
largest safety-net hospital in New England and with 13 affiliated Community Health 
Centers (CHCs) provides care for about 30% of Boston residents. The population of the 
study consists of patients with at least one diagnosis record of diabetes mellitus (ICD9 code 
250) between 01/01/2007–12/31/2012. For each patient in the above set, we extract the 
medical history (demographics, visit history, problems, procedures and department 
information) during the period 01/01/2001–12/31/2012. The data we process for these 
patients come from the hospital EHR and billing systems, which record admissions or visits 
                                                 
1 The terms detection rate and false alarm rate are commonly used in the machine learning community, while the 
terms sensitivity and specificity appear more often in the medical literature. 
and the primary diagnosis/reason. The diabetes-related medical history of the patients is 
described by various categories of medical factors (that we identified using feedback from 
doctors), which, along with some examples corresponding to each, are shown in Table II. 
As expected, many of the diagnoses and procedures are direct complications due to 
diabetes. Diabetes-related admissions are not trivially identifiable, and are revealed 
through the procedure described in the next subsection. Overall, this dataset consists of 
40,921 patients. 
 
Ontology  Examples 
Demographics  Sex, Age, Race 
Diagnoses  e.g., Diabetes mellitus with complications, Thyroid 
disorders, Hypertensive disease, Pulmonary heart 
disease, Heart failure, Aneurysm, Skin infections, 
Abnormal glucose tolerance test, Family history of 
diabetes mellitus 
Procedures (CPT or 
ICD9) 
e.g., Procedure on single vessel, Insertion of intraocular 
lens prosthesis at time of cataract extraction, Venous 
catheterization, Hemodialysis, Transfusion of packed 
cells 
Admissions  e.g., Diabetes (with and without) complications, Heart 
failure and shock, Deep Vein Thrombophlebitis, Renal 
failure, Chest pain, Chronic obstructive pulmonary 
disease, Nutritional & miscellaneous metabolic disorders, 
Bone Diseases & Arthropathies, Kidney & urinary tract 
infections, Acute myocardial infarction, O.R. procedures 
for obesity, Hypertension 
Laboratory Test 
Values  
Hematology, Chemistry, Urinalysis, Coagulation tests 
Vital Signs  e.g., Blood pressure, Pulse, Respiratory rate, 
Temperature, Body Mass Index (BMI) 
Blood Glucose 
Regulation Agents 
Insulin, Anti-hypoglycemic, Oral hypoglycemic agents, 
etc. 
Service By 
Department 
Inpatient (admit), Inpatient (observe), Outpatient, 
Emergency Room 
Table II: Medical factors. 
In more detail, with every patient visit to the hospital, at least one record with a medical 
factor and a time-stamp containing the admittance date (and the discharge date) is created. 
In order to organize all the information available in some uniform way for all patients, 
some pre-processing of the data is required. Details will be discussed in a later subsection. 
We will refer to the summarized information of the medical factors over a specific time 
interval as features. Each feature related to Diagnoses, Procedures CPT (Current 
Procedural Terminology), Procedures ICD9 (International Classification of Diseases, 9th 
edition) and visits to each Department is an integer count of such records for a specific 
patient during the specific time interval. Zero indicates the absence of any record.  
4.1 Identifying the diabetes-related hospitalizations/admissions 
Identifying the hospitalizations that could be attributed to diabetes is not a trivial task, 
because for financial reasons (i.e., higher reimbursement) many diabetes-related 
hospitalizations are recorded in the system as other types of admissions, e.g., heart-related. 
To that end, we conduct a complementary statistical study to determine which types of 
admissions are diabetes-related. For simplicity, we adopt the classic p-value approach. 
There are also alternative but more complex hypothesis testing methods, including the 
critical value test [36] and methods involving confidence intervals.[37]  
 
We consider all patients with at least one admission record between 01/01/2007− 
12/31/2012. From this set, patients with at least one diabetes mellitus record are assigned 
to the diabetic population, while the rest are assigned to the non-diabetic population. We 
list the union of all the unique admission types for both populations (732 unique types). 
The total number of admissions for the diabetic and non-diabetic populations is 𝑁ଵ ൌ47,452  and 𝑁ଶ ൌ 116,934 , correspondingly. For each type of admission 𝑑 , each admission event can be represented as a binary random variable that takes the value 1, if 
the hospitalization occurs because of this type of admission, or 0 otherwise. Thus, we can 
transform the two sets of admission records for the two populations into 0/1 sequences. By 
(statistically) comparing the proportions of 𝑑 in the two populations, we can infer whether 
admission 𝑑 was caused mainly by diabetes or not. 
 
At this point, we will elaborate on a statistical hypothesis test that involves sample 
differences of proportions.[38] Suppose we generate two sets of admissions of size 𝑁ଵ and 𝑁ଶ  drawn from the diabetic and the non-diabetic patient populations, respectively. Consider a specific admission type 𝑑 and suppose that it appears with probability 𝑝ଵ, out of all possible admission types, in the diabetic population. Similarly, a type 𝑑 admission 
appears with probability 𝑝ଶ  in the non-diabetic population. Given now the two sets of admissions from diabetics and non-diabetics of size 𝑁ଵ  and 𝑁ଶ , let 𝑃ଵ  and 𝑃ଶ  be the corresponding sample proportions of type 𝑑 admissions. We want to statistically compare 
𝑃ଵ and 𝑃ଶ and assess whether a type 𝑑 admission is more prevalent in the diabetics vs. the non-diabetics. Consider as the null hypothesis the case where 𝑝ଵ ൌ 𝑝ଶ , i.e., a type 𝑑 admission is equally likely in the two populations. Under the null hypothesis, the sampling 
distribution of differences in proportions is approximately normally distributed, with its 
mean and standard deviation given by 𝜇௉భି௉మ ൌ 0 and 𝜎௉భି௉మ ൌ ට𝑝𝑞ሺ ଵேభ ൅
ଵ
ேమሻ, where 𝑝 ൌ
ேభ௉భାேమ௉మ
ேభାேమ  is used as an estimate of the probability of a type 𝑑 admission in both populations 
and 𝑞 ൌ 1 െ 𝑝. By using the standardized variable 𝑧 ൌ ௉భି௉మఙುభషುమ we can assess if the results observed in the samples differ markedly from the results expected under the null 
hypothesis. We do that using the single sided p-value of the statistic 𝑧. The smaller the p-
value is, the higher the confidence we have in the alternative hypothesis or, equivalently, 
in the fact that the diabetic patients have higher chance of getting admission records of type 
𝑑 than the non-diabetic ones (since we consider the difference 𝑃ଵ െ 𝑃ଶ). We list admission types in increasing order of p-value and we set a threshold of p-value൑ 𝛼 ൌ 1𝐸 െ 4; 
admission types with p-value less than 𝛼 are considered to be attributed to diabetes.  
4.2 Data pre-processing 
The features are formed as combinations of different medical factors (instead of 
considering the factors as separate features) that better describe what happened to the 
patients during their visits to the hospital. Specifically, we formulate triplets that consist of 
a diagnosis, a procedure (or the information that no procedure was done) and the service 
department. An example of a complex feature (a triplet) is the diagnosis of ischemic heart 
disease that led to an adjunct vascular system procedure (procedure on a single vessel) 
while the patient was admitted to the inpatient care. Clearly, since each category can take 
one of several discrete values, a huge number of combinations should be considered. 
Naturally, not all possible combinations occur, which reduces significantly the total 
number of potential features that describe each patient. Also for each patient, we extract 
information about the diabetes type over their history (keeping only patients with Type II) 
and demographics including age, gender and race. 
 
Next, we present several data organization and pre-processing steps we take. For each 
patient, a target year is fixed and all past patient records are organized as follows. 
 Setting the target time interval to a calendar year. Based on some preliminary 
experiments we conducted, we observed that there is greater variability in the 
results when trying to predict hospitalizations in periods of time shorter than a year 
(e.g., predicting hospitalization in the next 1, 3 or 6 months). Thus, we have 
designed our experiment to predict hospitalizations in the target time interval of a 
year starting on the 1st of January and ending on the 31st of December.2 
 Selection of the target year. As a result of the nature of the data, the two classes are 
highly imbalanced. To increase the number of hospitalized patient examples, if a 
patient had only one hospitalization throughout 2007-2012, the year of 
hospitalization will be set as the target year. If a patient had multiple 
hospitalizations, a target year between the first and the last hospitalizations will be 
randomly selected. 2012 is set as the target year for patients with no hospitalization, 
so that there is as much available history for them as possible.  
 Removing patients with no record. Patients who have no records before the target 
year are removed, since there is nothing on which a prediction can be based. The 
                                                 
2 The fact that we have chosen calendar years and not a sliding time window is a design choice we have made.  
 
total number of patients left is 33,122, including the 26,478 patients with Type II 
diabetes under consideration. After this process, the proportion of hospitalized 
patients with Type II diabetes in the dataset is 13.48% (3570 out of 26,478). 
 Forming the complex features. We create a diagnoses-procedures-service 
department indicator triplet (complex feature) to keep track of which diagnosis 
occurs with which procedure and service department. The procedures that are not 
associated with any diabetes-related diagnosis are removed. Diagnoses in the 
dataset are listed in the most detailed level of the ICD9 coding system. We group 
together procedures that belong to the same ICD/CPT family, resulting in 31 
categories (out of 2004 in total). 
 Summarization of the complex features in the history of a patient. We form four 
time blocks for each medical factor. Time blocks 1, 2, and 3 summarize the medical 
factors over one, two, and three years before the target year, whereas the 4th time 
block averages all earlier records. Naturally not all combinations of diagnoses-
procedures-service department occur, and we only keep the triplets that occur; then 
adding the demographic features produces a 9402-dimensional vector of features 
characterizing each patient. 
 Reducing the number of complex features. We remove all the features that do not 
contain enough information for a significant amount of the population (less than 
1% of the patients), as they could not help us generalize. This leaves 320 complex 
medical and 3 demographic features.   
 Other detailed information. We also consider 245 more detailed medical features, 
including lab test values, vital signs and blood glucose regulation agents (see Table 
II). By calculating the average lab test values, average vital signs or existence of 
regulation agents in the 4 time blocks, we obtain 245x4=980 additional features. 
Removing features with standard deviation less than 1𝐸 െ 4, reduces the number 
of features to 945. Together with the features we described earlier, this results in 
945+3+320=1268 features. 
 Identifying the diabetes type. The ICD9 code for diabetes is assigned to category 
250 (diabetes mellitus). The fifth digit of the diagnosis code determines the type of 
diabetes and whether it is uncontrolled or not stated as uncontrolled. Keeping only 
the 26,478 patients with Type II diabetes, we have two types of diabetes diagnoses: 
Type II, not stated as uncontrolled (fifth digit 0), and Type II or unspecified type, 
uncontrolled (fifth digit 2). Based on these types, we count how many records of 
each type each patient had in the four time blocks before the target year, thus adding 
8 new features for each patient. 
 Splitting the data into a training set and a test set randomly. As is common in 
supervised machine learning, the population is randomly split into a training and a 
test set. Since from a statistical point of view, all the data points (patients’ features) 
are drawn from the same distribution, we do not differentiate between patients 
whose records appear earlier in time than others with later time stamps. A 
retrospective/prospective approach appears more often in the medical literature and 
is more relevant in a clinical trial setting, rather than in our algorithmic approach. 
What matters in our setting is that for each patient prediction we make 
(hospitalization/non-hospitalization in a target year), we only use that patient’s 
information before the target year. 
5. EXPERIMENTAL RESULTS AND DISCUSSION 
5.1 Performance evaluation 
We evaluate classification performance out-of-sample, i.e., in a test set not seen during 
training. Figure 2 and Figure 3 plot ROC and PRC curves for a variety of classification 
methods, respectively; Table III and Table IV list the corresponding AUCs and AUC-PRs 
(average and standard deviation of AUC and AUC-PR over 10 runs with different training 
and test sets). Parameter tuning was done for all methods using k-fold cross validation.  For 
ACC, the initial assignments of the positive samples to the clusters are obtained from k-
means clustering, and multi-start is implemented to find the best local optimum. The 
parameters used in (1) are set as follows. The number of clusters 𝐿 explicitly takes its 
values from {2, 3, 4} for all methods involving clustering; the soft-margin parameter for 
the negative class λି takes its values from {100, 10, 1, 0.1}; and the soft-margin parameter 
for the positive class λା is set equal to 𝐿λି. Some preliminary experiments led us to set the 
sparsity-controlling parameter 𝑇௟ ൌ 12  to save on computational cost. For ACC, we 
employ one more innovation to improve the prediction results. Specifically, for each 
cluster, we solve several instances of the per-cluster sparse SVM as follows. First, we solve 
the problem with all features and a fixed 𝑇௟. This has the effect of selecting a subset of the 
features. Then, we solve a 2nd instance of the problem using only the subset of the features 
selected. We keep iterating in this fashion until a relatively small subset of features is being 
used. 
 
Figure 2: ROC curves for various classification methods. 
 
For all methods 40% of the data are used for training and the rest for testing. The training 
data are normalized to have zero mean and unit standard deviation and are balanced by 
down-sampling the negative population. We also compare ACC with two other hierarchical 
approaches that first cluster the data using the k-means clustering[39] and then perform the 
classification task using linear SVM (we denote the method as CT-LSVM) and sparse (𝑙ଵ-
regularized) linear SVM (we denote the method as CT-SLSVM). Only the best results for 
CT-LSVM (obtained under 𝐿 ൌ 2) and CT-SLSVM (obtained under 𝐿 ൌ 2) are presented.  
 
Figure 3: PRC curves for various classification methods. 
 
Clustering with ACC can use a subset of “diagnostic” features (subset ∁ in Alg. 2), since 
these are the features that better delineate across different types of diabetes complications. 
We base, however, the clustering in our experiments on all features due to the fact that 
almost all triplet features are related to “diagnostic” features. The results indicate that 
Gradient Tree Boosting (GBDT) outperforms all other methods in terms of AUC in Table 
III and AUC-PR in Table IV. Random forest comes 2nd in terms of AUC with ACC close 
behind, while ACC comes 2nd in terms of AUC-PR with random forest third. Both GBDT 
and random forests produce a very complex classifier involving hundreds of decision trees. 
As such they lack interpretability, which, as we argued, is a critical consideration.   
 
ACC, on the other hand, is able to detect the hidden positive clusters and identify why a 
specific patient is labeled as hospitalized. Among ACC variants, the best performance is 
obtained for 𝐿 ൌ 2 clusters, with the performance of the other variants using more clusters 
being close behind. The fact that ACC (𝐿 ൌ 2) is better than ACC (𝐿 ൌ 1) illustrates that 
appropriate clustering can not only produce meaningful cluster interpretations, but also 
improve classification performance compared to the base (SVM) classifier used in each 
cluster. It is interesting that ACC performs quite well even though the resulting classifiers 
are relatively sparse and do not use many features. This also makes them easy to 
implement.  Notice that ACC utilizes sparse linear SVM as the base classifier. According 
to Theorem II, sparsity (i.e., small 𝐷) leads to smaller generalization error. ACC also 
proved to be efficient from a computational point of view, since in our implementation, it 
is faster than random forests by a factor of 3, and faster than Gradient Tree Boosting 
(GBDT) by a factor of 5.3. Fig. 4 shows how the objective function decreases during ACC 
iterations.  
 
Figure 4: Objective function value as a function of ACC iterations. 
 
 
 
Method avg AUC std AUC Method avg 
AUC 
std AUC 
ACC, 𝐿 ൌ 1 0.8814 0.0025 Linear SVM 0.8531 0.0029 
ACC, 𝐿 ൌ 2 0.8861 0.0032 RBF SVM 0.8594 0.0037 
ACC, 𝐿 ൌ 3 0.8829 0.0039 sparse logistic  
regression 
0.8613 0.0027 
ACC, 𝐿 ൌ 4 0.8812 0.0027 Random Forests 0.8882 0.0054 
CT-SLSVM (𝐿 ൌ 2) 0.8522 0.0034 Gradient Tree 
Boosting (GBDT) 
0.9190 0.0033 
CT-LSVM (𝐿 ൌ 2) 0.8502 0.0072    
Table III: Average (avg) and standard deviation (std) of the Area Under ROC 
Curve (AUC) of various methods we have experimented with over 10 runs. 
Method avg  
AUC-PR 
std  
AUC-PR 
Method avg  
AUC-
PR 
std  
AUC-PR 
ACC, 𝐿 ൌ 1 0.6200 0.0104 Linear SVM 0.5512 0.0129 
ACC, 𝐿 ൌ 2 0.6214 0.0106 RBF SVM 0.5758 0.0110 
ACC, 𝐿 ൌ 3 0.6085 0.0115 sparse logistic 
regression 
0.5752 0.0091 
ACC, 𝐿 ൌ 4 0.6035 0.0109 Random Forests 0.6003 0.0159 
CT-SLSVM (𝐿 ൌ 2) 0.5518 0.0124 Gradient Tree 
Boosting (GBDT) 
0.7272 0.088 
CT-LSVM (𝐿 ൌ 2) 0.5355 0.0175    
Table IV: Average and standard deviation of the Area under Precision-Recall 
Curve (AUC-PR) of various methods we have experimented with over 10 runs. 
 
In an attempt to interpret the ACC clusters, we list in Table V the mean value over each 
cluster of the features used by the per-cluster classifiers. This is done for a single repetition 
of the experiment and 𝐿 ൌ 2 , yielding interesting clusters and highlighting the 
interpretative power of ACC. We concentrate on the most distinguishable features in the 
clusters. Specifically, for each feature we used Welch’s t-test to compute a two-tailed p-
value, where the null hypothesis was that the two cohorts (patients in cluster 1 and cluster 
2) have equal means. All the features listed in Table V have a p-value less than 0.05, 
providing strong evidence against the null hypothesis. ACC assigns 51.87% of 
hospitalized patients in the training set to cluster 2 and the remaining to cluster 1. We 
observe that hospitalized patients in Cluster 1 are older, have more hypertension and heart 
failure (measured in avg. number of diagnoses), take more drugs for heart diseases 
(measured in average number of drugs taken), and have indicators of renal disease (higher 
serum creatinine values and higher blood urea nitrogen). Hospitalized patients in Cluster 2 
have diabetes with not as significant heart disease complications, indicated as diabetes with 
no associated procedures, hospitalizations, and, in general, not stated as uncontrolled.  This 
is quite interesting and consistent with earlier work that identified the relationship between 
diabetes and specific complications (heart disease in our case). [18, 40] It appears, that the 
method is identifying a cluster of patients with diabetes and heart disease and is using a 
different classifier for these patients compared to the remaining patients.   
 
Variables 
Mean 
in 
Cluster 
1 
Mean in 
Cluster 2 p-value Variables 
Mean 
in 
Cluster 
1 
Mean 
in 
Cluster 
2 
p-value 
Age 72.98 66.11 1.04E-18 Creatinine, serum 1.27 0.96 7.85E-11 
Hypertensive 
Diseases 
(diagnoses) 
1.52 1.16 5.44E-04 
Glucose, 
point of 
care 
148.65 162.23 7.33E-38 
Heart Failure  
(diagnoses) 0.31 0.09 5.69E-09 
Platelet 
count 226.40 263.63 1.67E-44 
Diabetes 
Mellitus No 
Procedure 
Emergency 
Room 
0.13 0.23 6.57E-07 
Review/Or
der Lab 
tests 
0.43 0.25 2.70E-19 
Diabetes 
Mellitus No 
Procedure In 
Patient 
(Observe) 
0.94 1.48 2.92E-10 
Review/Or
der 
Radiology 
0.23 0.14 3.87E-08 
Diabetes 
Type II, not 
stated as 
uncontrolled 
1.86 3.70 1.73E-25 
Review/Or
der other 
tests 
0.22 0.10 2.34E-17 
Cardiology-
related 
Medicine 
0.75 0.18 3.12E-16 
Urea 
nitrogen, 
blood 
21.77 16.80 3.42E-26 
Table V: Average feature values in the clusters produced by ACC (𝐿 ൌ 2). 
 
We note that the p-values in Table V are reported without adjustment for multiple 
hypothesis testing, i.e., each p-value corresponds to the probability that the cluster means 
of each variable in isolation are as reported under the null hypothesis. In order to control 
the false discovery rate of the multiple hypothesis test, we applied the Benjamini-
Yekutieli procedure to adjust the p-values.[41, 42] All of the adjusted p-values are below 
1E-6 except for two variables: “Hypertensive Diseases (diagnoses)” and “Diabetes 
Mellitus No Procedure Emergency Room”, which have adjusted p-values equal to 1.77E-
03 and 2.30E-06, respectively. These can be seen as sufficiently small to provide strong 
evidence for rejecting the null hypothesis. 
 
5.2 Cost-benefit analysis 
We next assess the potential financial benefits of using a predictive model like the one we 
developed. We take year 2012 as an example; our dataset has 𝑁ு ൌ 619 hospitalized and 𝑁ேு ൌ22,616 non-hospitalized patients that year. According to [43], the average cost per hospitalization due to diabetes with complications is $9,500. Thus, assuming no spending 
on the non-hospitalized patients and a single hospitalization for the hospitalized, the 
expected cost per patient if no prevention measures are implemented is:  
ଽହ଴଴ ேಹ
ேಹାேಿಹ ൌ $253.   (3) Suppose now we elect to utilize the predictive model and operate at a point on the ROC 
curve corresponding to a roughly 𝑃஽ ൌ81% detection rate and a 𝑃ி஺ ൌ20% false alarm rate (see Figure 2). We bring each patient predicted to be hospitalized to the clinic, at a cost of 
$220 for a visit according to [43], and prescribe an 1-year-supply of drugs at an average 
cost of $100. Additional recommendations involving lifestyle changes and social support 
may also be offered. Accounting for only the cost of the visit and the drugs, the cost of 
preventive measures is $320 per patient. Notice that this overestimates the cost because for 
some patients predicted to be hospitalized, the physician may decide that additional drugs 
are not needed. For patients the predictive model misses, there is no action and they would 
receive their normal care. Let 𝑃ௌ the probability that prevention is effective and averts the hospitalization. It follows that the cost per patient becomes: 
ଽହ଴଴ ேಹሺଵି௉ವሻାଷଶ଴ேಿಹ௉ಷಲାଷଶ଴ேಹ௉ವ௉ೄାሺଽହ଴଴ାଷଶ଴ሻேಹ௉ವሺଵି௉ೄሻ
ேಹାேಿಹ  .  (4) A simple calculation implies that the above quantity is less than $253 for 𝑃ௌ ൐ 0.34. Taking 𝑃ௌ ൌ 0.5 leads to an expected cost per patient equal to $219, resulting in savings of $34 per patient. If such a model was used for each patient with diabetes in the U.S. during 
2002 (29.1 million), the overall savings amount to about $1 billion for the year! This is 
about 17% of the overall amount spent on preventable diabetes-related hospitalizations 
each year.    
5.3 Limitations of our study 
While the results we have presented seem very promising and we have provided theoretical 
guarantees about the generalization ability of our proposed methodology, our study 
naturally suffers from data limitations. This is because we focus on patients from a specific 
hospital, coming mainly from lower socioeconomic classes. Our data come exclusively 
from the BMC system and we do not have access to any data corresponding to visits or 
treatment outside BMC. Specifically, patients our methods find to be at a high risk of 
hospitalization based on the available data, may have received treatment elsewhere which 
reduced their hospitalization risk, eventually avoiding a hospitalization we may have 
predicted. Moreover, patients which we predict will not be hospitalized may have been 
seen outside BMC and data captured for them may explain a future hospitalization. In both 
cases, in the absence of data about a patient, the predictive model is powerless. We 
conjecture, however, that the effect of such lack of data does not substantially alter the 
metrics on the predictive power of our methods. The main reason is that BMC patients are 
typically seen within the system because they lack the financial resources to receive care 
elsewhere. In any case, if additional data (e.g., from insurance claims) become available, 
they can be readily used by our methods to improve the predictions.  
6. CONCLUSIONS  
Diabetes is the fastest growing chronic condition causing a number of preventable 
hospitalizations. Diabetes is also associated with serious complications, such as heart 
disease and stroke, retinopathy, kidney failure, and lower-limb amputation. Early detection 
and treatment can slow down the progression of the disease and result in better health 
outcomes and huge savings. We considered the problem of predicting diabetes-related 
hospitalizations using information in the Electronic Health Records of the patients. We 
introduced a statistical procedure to identify the diabetes-related admissions and we 
experimented with a number of machine learning methods that predict hospitalizations in 
a target year for diabetic patients. With a 20% false alarm rate, we can correctly predict 
about 81% of the hospitalized patients while providing insight as to why each prediction is 
made. To that end, we developed a novel clustering and classification framework (ACC) 
that jointly discriminates between hospitalized and non-hospitalized patients and discovers 
clusters of patients with key factors, different in each cluster, that lead to hospitalization. 
The identification of the clusters has the significant advantage of interpretability, which is 
crucial in the medical domain. We proved convergence of the new algorithm and 
established theoretical generalization guarantees. The proposed algorithm has wider 
applicability and the potential to be applied to other medical case studies, helping, for 
example, discover cohorts of patients with similar underlying issues and devising cohort-
specific predictive models.  
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APPENDICES 
The appendices include proofs of the theorems presented in the body of the manuscript. 
 
APPENDIX A 
1. Proof of Theorem I 
 
Theorem I For any ∁, the ACC process converges. 
 
Proof: 
At each alternating cycle, for each cluster 𝑙 we train a Sparse Linear SVM (SPLSVM) with 
positive samples of that cluster combined with all negative samples. This produces an 
optimal value 𝑂௟  and the corresponding classifier ൫𝜷௟, 𝛽଴௟ ൯. Specifically, the formulation is: 
𝑂௟ ൌ 𝑚𝑖𝑛𝜷೗,ఉబ೗
1
2 ‖𝜷
௟‖ଶ ൅ 𝜆ା ෍ 𝜉௜௟
ே೗శ
௜ୀଵ
൅ 𝜆ି ෍ 𝜁௝௟
௺ష
௝ୀଵ
 
𝑠. 𝑡. ෍ห𝜷ௗ௟ ห ൑ 𝑇௟,
஽
ௗୀଵ
 
𝜉௜௟ ൒ 1 െ 𝑦௜ା𝛽଴௟ െ ∑ 𝑦௜ା𝛽ௗ௟ 𝑥௜,ௗା , ∀𝑖𝜖ሼ1, … , 𝑁௟ାሽ,஽ௗୀଵ   (A.1) 
𝜁௝௟ ൒ 1 െ 𝑦௝ା𝛽଴௟ െ ෍ 𝑦௝ି 𝛽ௗ௟ 𝑥௝,ௗି, ∀𝑗 ∈ ሼ1, … , 𝑁ିሽ,
஽
ௗୀଵ
 
𝜉௜௟, 𝜁௝௟ ൒ 0, ∀𝑖𝜖ሼ1, … , 𝑁௟ାሽ, ∀𝑗 ∈ ሼ1, … , 𝑁ିሽ. 
We use the sum of the optimal objective function values in (A.1) across different clusters 
to prove convergence. We have 
𝑍 ൌ ∑ 𝑂௟ ൌ ∑ ሺଵଶ ‖𝜷௟‖ଶ ൅ 𝜆ି ∑ 𝜁௝௟௺
ష
௝ୀଵ ሻ௅௟ୀଵ ൅ 𝜆ା ∑ 𝜉௜௟ሺ௜ሻே೗
శ
௜ୀଵ
௅௟ୀଵ , 
where 𝑙ሺ𝑖ሻ  maps sample 𝑖  to cluster 𝑙ሺ𝑖ሻ , ∑ 𝑁௟ା ൌ 𝑁ା௅௟ୀଵ , and 𝜷௟, 𝛽଴௟ , 𝜁௝௟,  and 𝜉௜௟ሺ௜ሻ  are 
optimal solutions of (A.1) for each 𝑙. Now, let us consider the change of 𝑍 at each iteration 
of the ACC procedure. 
 
First, we consider the re-clustering step given SLSVMs. During the re-clustering step, the 
classifier and slack variables for negative samples are not modified. Only the 𝜉௜௟ሺ௜ሻ  get modified since the assignment functions 𝑙ሺ𝑖ሻ change. When we switch positive sample 𝑖 
from cluster 𝑙ሺ𝑖ሻ to 𝑙∗ሺ𝑖ሻ, we can simply assign value 𝜉௜௟ሺ௜ሻ to 𝜉௜௟
∗ሺ௜ሻ. Therefore, the value of 
𝑍 does not change during the re-clustering phase and takes the form 
𝑍 ൌ ∑ ቀଵଶ ‖𝜷௟‖ଶ ൅ 𝜆ା ∑ 𝜉௜௟ ൅ሼ௜:௟ሺ௜ሻୀ௟ሽ 𝜆ି ∑ 𝜁௝௟௺
ష
௝ୀଵ ቁ௅௟ୀଵ . 
Next, given new cluster assignments, we re-train the local classifiers by resolving problem 
(A.1) for each cluster 𝑙. Notice that re-clustering was done subject to the constraint in Eq. 
(2) (see Alg. 1). Since 𝑦௜ା= 1, we have 
𝜉௜௟ሺ௜ሻ ൒ 1 െ 𝑦௜ା𝛽଴௟ሺ௜ሻ െ ∑ 𝑦௜ା𝛽ௗ௟ሺ௜ሻ𝑥௜,ௗା  ൒஽ௗୀଵ 1 െ 𝑦௜ା𝛽଴௟
∗ሺ௜ሻ െ ∑ 𝑦௜ା𝛽ௗ௟
∗ሺ௜ሻ𝑥௜,ௗା  ஽ௗୀଵ . 
The first inequality is due to 𝜉௜௟ሺ௜ሻ being feasible for (A.1). The second inequality is due to 
𝑦௜ା ൌ 1 and Eq. (2) in Alg. 1. Thus, by assigning 𝜉௜௟ሺ௜ሻ to 𝜉௜௟
∗ሺ௜ሻ  it follows that the 𝜉௜௟
∗ሺ௜ሻ  
remain feasible for problem (A.1). Given that the remaining decision variables do not 
change, ሺ𝜷௟, 𝛽଴௟ , 𝜁௝௟, 𝜉௜௟ሺ௜ሻ, ∀𝑖 ൌ 1, … , 𝑁௟ା, ∀𝑗 ൌ 1, … , 𝑁ିሻ  forms a feasible solution of 
problem (A.1). This solution has a cost equal to 𝑂௟. Re-optimizing can produce an optimal 
value that is no worse. It follows that in every iteration of ACC, Z is monotonically non-
increasing. Given that 𝑍 is bounded below by zero, we establish the convergence of ACC. 
      
 
APPENDIX B 
1. Proof of Theorem II 
 
Theorem II The VC-dimension of the class 𝐻 is bounded by ሺ𝐿 ൅ 1ሻ𝐿ሺ𝐷 ൅
1ሻ log ሺ𝑒 ሺ௅ାଵሻ௅ଶ ሻ. Then for any 𝜌 ∈ ሺ0,1ሻ, with probability at least 1 െ 𝜌, 𝑅 ൑ 𝑅ே ൅
2ඨ2 ௏ಲ಴಴௟௢௚
మ೐ಿ
ೇಲ಴಴ା௟௢௚
మ
ഐ
ே . 
 
 
Proof: 
The proof is based on Lemma 2 of [44]. Given an assignment of positive sample 𝑖 to cluster 
𝑙ሺ𝑖ሻ define 𝐿 clustering functions 
𝑔௟ሺ௜ሻ ൌ ൜1,          𝑖𝑓 𝑙ሺ𝑖ሻ ൌ 𝑙,0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒. 
Hence, sample 𝑖 is assigned to cluster 𝑎𝑟𝑔𝑚𝑎𝑥௟𝑔௟ሺ𝑖ሻ. This can be viewed as the output of ሺ𝐿 െ 1ሻ𝐿 2⁄  comparisons between pairs of 𝑔௟భ  and 𝑔௟మ , where 1 ൑ 𝑙ଵ ൑ 𝑙ଶ ൑ 𝐿 . This pairwise comparison could be further transformed into a boolean function (i.e., 𝑠𝑔𝑛ሺ𝑔௟భ െ𝑔௟మሻ)). Together with the 𝐿 classifiers (one for each cluster), we have a total of ሺ𝐿 ൅ 1ሻ𝐿 2⁄  boolean functions. Among all these boolean functions, the maximum VC-dimension is 𝐷 ൅
1, due to 𝐷∁ ൑ 𝐷. Therefore, by Lemma 2 of [45], the VC-dimension of the function family 
𝐻  is bounded by 2 ቀሺ௅ାଵሻ௅ଶ ቁ ሺ𝐷 ൅ 1ሻlog ሺ𝑒
ሺ௅ାଵሻ௅
ଶ ሻ  or equivalently ሺ𝐿 ൅ 1ሻ𝐿ሺ𝐷 ൅
1ሻlog ሺ𝑒 ሺ௅ାଵሻ௅ଶ ሻ. The generalization guarantees follow from [26].           
